相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae
Jonathan W. Betts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Combination therapy for carbapenem-resistant Gram-negative bacteria
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
Jae H. Hong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin
Cornelius J. Clancy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin
Jadwiga Handzlik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Outbreak Caused by an Ertapenem-Resistant, CTX-M-15-Producing Klebsiella pneumoniae Sequence Type 101 Clone Carrying an OmpK36 Porin Variant
Aggeliki Poulou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Single or in Combination Antimicrobial Resistance Mechanisms of Klebsiella pneumoniae Contribute to Varied Susceptibility to Different Carbapenems
Yu-Kuo Tsai et al.
PLOS ONE (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and SAR-study for novel arylpiperazine derivatives of 5-arylidenehydantoin with α1-adrenoceptor antagonistic properties
Jadwiga Handzlik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones
A. Novais et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Role of Klebsiella pneumoniae LamB Porin in Antimicrobial Resistance
Laura Garcia-Sureda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Neurotoxic effects associated with antibiotic use: management considerations
Marie F. Grill et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Clinical Predictive Value (or Lack Thereof) of the Results of In Vitro Antimicrobial Susceptibility Tests
G. V. Doern et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Optimized Nile Red Efflux Assay of AcrAB-TolC Multidrug Efflux System Shows Competition between Substrates
Juegen A. Bohnert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
An Ertapenem-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Clone Carries a Novel OmpK36 Porin Variant
Aurora Garcia-Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Abraham Borer et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency
Xuan Ding Wang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Extended-spectrum beta-lactamases and the permeability barrier
L. Martinez-Martinez
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Collateral damage of flomoxef therapy:: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases
Chen-Hsiang Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE
Frank M. Kaczmarek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA
G Bauer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance
A Doménech-Sánchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
